Consenting participants that pass the baseline CBB testing (CBB ≥80) will be randomised (1:1) to receive either postoperative sedation with DEX infusion for 24 hours after surgery in the ICU or sedation per institutional practice. All other aspects of pre/intra/postoperative care will be in accordance with standard institutional practice at the discretion of the clinical team including specific induction/maintenance anaesthetic drugs, surgical care and postoperative care to reduce heterogeneity between study groups and increase generalisability. In addition to the primary and secondary outcome measures, the research team will record demographical data including age, gender, ASA (American Soceity of Anesthesiologists' Physical Status Classification) and highest level of education.
Copyright and License information: ©2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Note: The content above has been extracted from a research article, so it may not display correctly.